Artiva Biotherapeutics, Inc. (ARTV) › Capital ExpendituresArtiva Biotherapeutics, Inc. (ARTV) — Capital ExpendituresAnnual figures by period end, from SEC filings.2023-12-31: $3.26M2024-12-31: $642.0K2025-12-31: $2.59M$2.59M2023-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$2.59M+303.0%2026-03-10From 2025-01-012024-12-31$642.0K-80.3%2026-03-10From 2024-01-012023-12-31$3.26M—2025-03-24From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)